Cited by

• Gaucher disease provides a unique window into Parkinson disease pathogenesis.

  Hertz E, Chen Y, Sidransky E. Hertz E, et al. Nat Rev Neurol. 2024 Sep;20(9):526-540. doi: 10.1038/s41582-024-00999-z. Epub 2024 Aug 6. Nat Rev Neurol. 2024. PMID: 39107435 Review.
• Classification and Genotype-Phenotype Relationships of GBA1 Variants: MDSGene Systematic Review.

  Rossi M, Schaake S, Usnich T, Boehm J, Steffen N, Schell N, Krüger C, Gül-Demirkale T, Bahr N, Kleinz T, Madoev H, Laabs BH, Gan-Or Z, Alcalay RN, Lohmann K, Klein C. Rossi M, et al. Mov Disord. 2025 Apr;40(4):605-618. doi: 10.1002/mds.30141. Epub 2025 Feb 10. Mov Disord. 2025. PMID: 39927608 Free PMC article.
• Differences in Sex-Specific Frequency of Glucocerebrosidase Variant Carriers and Familial Parkinsonism.

  Ortega RA, Bressman SB, Raymond D, Ozelius LJ, Wang C, Bennett SAL, Saunders-Pullman R. Ortega RA, et al. Mov Disord. 2023 Apr;38(4):714-715. doi: 10.1002/mds.29353. Mov Disord. 2023. PMID: 37061880 Free PMC article. No abstract available.
• Is GBA1 mutation status a game-changer for impulse control behaviour in Parkinson's disease?

  Kresojević N, Marković V, Geratović C, Lukić MJ, Tomić A, Dobričić V, Stanković I, Stojković T, Dragašević N, Šarčević M, Janković M, Marjanović A, Novaković I, Kostić V, Svetel M, Petrović I. Kresojević N, et al. Neurol Sci. 2025 Aug 26. doi: 10.1007/s10072-025-08448-5. Online ahead of print. Neurol Sci. 2025. PMID: 40855369
• Role of GBA variants in Lewy body disease neuropathology.

  Walton RL, Koga S, Beasley AI, White LJ, Griesacker T, Murray ME, Kasanuki K, Hou X, Fiesel FC, Springer W, Uitti RJ, Fields JA, Botha H, Ramanan VK, Kantarci K, Lowe VJ, Jack CR, Ertekin-Taner N, Savica R, Graff-Radford J, Petersen RC, Parisi JE, Reichard RR, Graff-Radford NR, Ferman TJ, Boeve BF, Wszolek ZK, Dickson DW, Ross OA, Heckman MG. Walton RL, et al. Acta Neuropathol. 2024 Mar 12;147(1):54. doi: 10.1007/s00401-024-02699-w. Acta Neuropathol. 2024. PMID: 38472443 Free PMC article.